vs

Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and D-Wave Quantum Inc. (QBTS). Click either name above to swap in a different company.

D-Wave Quantum Inc. is the larger business by last-quarter revenue ($2.8M vs $1.6M, roughly 1.7× bioAffinity Technologies, Inc.). bioAffinity Technologies, Inc. runs the higher net margin — -197.0% vs -1538.0%, a 1341.0% gap on every dollar of revenue. On growth, D-Wave Quantum Inc. posted the faster year-over-year revenue change (19.2% vs -27.8%). bioAffinity Technologies, Inc. produced more free cash flow last quarter ($-2.6M vs $-20.0M). Over the past eight quarters, D-Wave Quantum Inc.'s revenue compounded faster (-2.7% CAGR vs -18.6%).

bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.

D-Wave Quantum Inc. is a quantum computing company with locations in Palo Alto, California and Burnaby, British Columbia. D-Wave claims to be the world's first company to sell computers that exploit quantum effects in their operation. D-Wave's early customers include Lockheed Martin, the University of Southern California, Google/NASA, and Los Alamos National Laboratory.

BIAF vs QBTS — Head-to-Head

Bigger by revenue
QBTS
QBTS
1.7× larger
QBTS
$2.8M
$1.6M
BIAF
Growing faster (revenue YoY)
QBTS
QBTS
+47.0% gap
QBTS
19.2%
-27.8%
BIAF
Higher net margin
BIAF
BIAF
1341.0% more per $
BIAF
-197.0%
-1538.0%
QBTS
More free cash flow
BIAF
BIAF
$17.5M more FCF
BIAF
$-2.6M
$-20.0M
QBTS
Faster 2-yr revenue CAGR
QBTS
QBTS
Annualised
QBTS
-2.7%
-18.6%
BIAF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BIAF
BIAF
QBTS
QBTS
Revenue
$1.6M
$2.8M
Net Profit
$-3.1M
$-42.3M
Gross Margin
64.8%
Operating Margin
-196.9%
-1266.0%
Net Margin
-197.0%
-1538.0%
Revenue YoY
-27.8%
19.2%
Net Profit YoY
-5.7%
50.8%
EPS (diluted)
$-3.59
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIAF
BIAF
QBTS
QBTS
Q4 25
$1.6M
$2.8M
Q3 25
$1.4M
$3.7M
Q2 25
$1.3M
$3.1M
Q1 25
$1.9M
$15.0M
Q4 24
$2.2M
$2.3M
Q3 24
$2.4M
Q2 24
$2.4M
$2.2M
Q1 24
$2.4M
$2.5M
Net Profit
BIAF
BIAF
QBTS
QBTS
Q4 25
$-3.1M
$-42.3M
Q3 25
$-5.1M
$-140.0M
Q2 25
$-4.1M
$-167.3M
Q1 25
$-2.7M
$-5.4M
Q4 24
$-3.0M
$-86.1M
Q3 24
$-2.0M
Q2 24
$-2.1M
$-17.8M
Q1 24
$-2.0M
$-17.3M
Gross Margin
BIAF
BIAF
QBTS
QBTS
Q4 25
64.8%
Q3 25
71.4%
Q2 25
63.8%
Q1 25
92.5%
Q4 24
63.8%
Q3 24
Q2 24
63.6%
Q1 24
67.3%
Operating Margin
BIAF
BIAF
QBTS
QBTS
Q4 25
-196.9%
-1266.0%
Q3 25
-158.6%
-741.8%
Q2 25
-198.2%
-856.3%
Q1 25
-141.7%
-75.3%
Q4 24
-133.5%
-876.2%
Q3 24
-84.0%
Q2 24
-87.1%
-863.0%
Q1 24
-80.8%
-710.6%
Net Margin
BIAF
BIAF
QBTS
QBTS
Q4 25
-197.0%
-1538.0%
Q3 25
-349.3%
-3743.9%
Q2 25
-319.9%
-5406.4%
Q1 25
-143.5%
-36.1%
Q4 24
-134.4%
-3727.9%
Q3 24
-85.1%
Q2 24
-88.0%
-814.4%
Q1 24
-81.5%
-702.3%
EPS (diluted)
BIAF
BIAF
QBTS
QBTS
Q4 25
$-3.59
$-0.13
Q3 25
$-4.74
$-0.41
Q2 25
$-0.17
$-0.55
Q1 25
$-0.16
$-0.02
Q4 24
$-17.27
$-0.43
Q3 24
$-4.84
Q2 24
$-0.19
$-0.10
Q1 24
$-0.20
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIAF
BIAF
QBTS
QBTS
Cash + ST InvestmentsLiquidity on hand
$6.4M
$884.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3M
$852.2M
Total Assets
$11.0M
$915.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIAF
BIAF
QBTS
QBTS
Q4 25
$6.4M
$884.5M
Q3 25
$7.7M
$836.2M
Q2 25
$802.8K
$819.3M
Q1 25
$444.7K
$304.3M
Q4 24
$1.1M
$178.0M
Q3 24
$756.6K
Q2 24
$801.3K
Q1 24
$2.5M
Stockholders' Equity
BIAF
BIAF
QBTS
QBTS
Q4 25
$7.3M
$852.2M
Q3 25
$8.9M
$670.6M
Q2 25
$-2.1M
$694.3M
Q1 25
$1.4M
$207.4M
Q4 24
$2.6M
$62.6M
Q3 24
$3.1M
Q2 24
$3.4M
$-21.5M
Q1 24
$5.3M
$-37.0M
Total Assets
BIAF
BIAF
QBTS
QBTS
Q4 25
$11.0M
$915.8M
Q3 25
$11.5M
$865.8M
Q2 25
$4.8M
$843.6M
Q1 25
$5.5M
$325.6M
Q4 24
$6.5M
$199.9M
Q3 24
$6.6M
Q2 24
$6.7M
$61.8M
Q1 24
$8.0M
$48.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIAF
BIAF
QBTS
QBTS
Operating Cash FlowLast quarter
$-2.6M
$-18.4M
Free Cash FlowOCF − Capex
$-2.6M
$-20.0M
FCF MarginFCF / Revenue
-160.7%
-727.9%
Capex IntensityCapex / Revenue
0.0%
60.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.4M
$-75.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIAF
BIAF
QBTS
QBTS
Q4 25
$-2.6M
$-18.4M
Q3 25
$-2.5M
$-19.0M
Q2 25
$-2.6M
$-15.3M
Q1 25
$-1.6M
$-19.3M
Q4 24
$-1.7M
$2.0M
Q3 24
$-1.7M
Q2 24
$-1.5M
$-14.5M
Q1 24
$-2.3M
$-12.1M
Free Cash Flow
BIAF
BIAF
QBTS
QBTS
Q4 25
$-2.6M
$-20.0M
Q3 25
$-2.5M
$-20.1M
Q2 25
$-2.7M
$-16.0M
Q1 25
$-1.7M
$-19.7M
Q4 24
$-1.7M
$1.1M
Q3 24
$-1.7M
Q2 24
$-1.6M
$-15.0M
Q1 24
$-2.4M
$-12.4M
FCF Margin
BIAF
BIAF
QBTS
QBTS
Q4 25
-160.7%
-727.9%
Q3 25
-171.8%
-536.5%
Q2 25
-209.6%
-518.1%
Q1 25
-91.3%
-131.4%
Q4 24
-76.0%
46.2%
Q3 24
-73.1%
Q2 24
-65.1%
-687.7%
Q1 24
-99.2%
-504.0%
Capex Intensity
BIAF
BIAF
QBTS
QBTS
Q4 25
0.0%
60.3%
Q3 25
0.3%
27.2%
Q2 25
1.1%
24.2%
Q1 25
2.7%
2.9%
Q4 24
0.0%
41.1%
Q3 24
0.4%
Q2 24
1.2%
25.0%
Q1 24
1.7%
12.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIAF
BIAF

Segment breakdown not available.

QBTS
QBTS

Transferred Over Time$2.4M89%
Other$306.0K11%

Related Comparisons